Germ Cell Tumor and Testicular Tumor DNA Registry
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMemorial Sloan Kettering Cancer Center
About this trial
This study is being done to create a registry to help us learn more about germ cell tumors (GCT) and other testicular tumors. The registry will include people with these tumors and also relatives and unrelated people without these tumors. This study will help us learn more about the prevention, diagnosis, treatment and outcome of these tumors. Studying relatives of patients and people unrelated to patients with GCT and other testicular tumors will help us understand why some people get these tumors and why some people don't.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Must be ≥ 18 years of age AND
Must be an English-speaker AND
Must have a diagnosis or suspicion of germ cell tumor and/or a testicular mass
Must be ≥ 18 years of age AND
Disqualifiers
None
Trial population
At MSKCC, the following outpatient clinics will be used to recruit GCT and testicular tumor cases and controls: Urology (Department of Surgery), Gynecologic Oncology (Department of Surgery) Clinical Genetics, Genitourinary Oncology (Department of Medicine), and Gynecologic Medical Oncology (Department of Medicine).
Trial design
Design model
Other
Time perspective
Prospective
Treatments tested in this trial
Questionnaires
Behavioralsample of blood or saliva
Other interventionA sample of blood or saliva will be obtained for DNA extraction. Approximately 2-4 tubes of blood will be collected or one tablespoon of saliva. If a participant has already provided a DNA sample for another MSKCC IRB approved protocol, they may not need to provide an additional sample.
Treatment groups
1,000 Participants
are divided into 3 treatment groupsGroup A: A: suspicion of germ cell tumor and/or a testicular mass2 interventions
Group B: B: family members of Group A2 interventions
Group C: C: healthy controls unrelated to Group A or B2 interventions
Trial outcomes
Primary outcomes
1
creation of a Germ Cell Tumor and testicular tumor registry
We will collect clinical data including diagnosis date, pathology, family history, and risk factors in patients with GCT-TT.
Time frame
5 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov